PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498801
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498801
Electroporation Instrument Market size was valued at USD 236.9 Million in 2023, expanding at a CAGR of 7.00% from 2024 to 2032.
Electroporation instruments are based on the electrical conductivity of biomolecules. These tools serve to create permeability in the cell's plasma membrane, allowing molecules of interest to pass through passively. Electroporation equipment facilitates the introduction of foreign proteins into various live cells. A solution is made up of both host cells and the substances that will be transported through them. Subsequently, an electric current is passed through the solution to promote the transmission. Electroporation tools are used in biochemistry, biotechnology, molecular biology, and biomedical research to introduce DNA, chemicals, or medications into host cells.
Electroporation Instrument Market- Market Dynamics
Rising Chronic Diseases will Boost Electroporation Instrument Market Growth
The rising number of chronic diseases like cancer, HIV, and similar conditions will drive the growth of the electroporation instrument market in the predicted timeframe. According to the 2022 report from the World Health Organization, cancer was responsible for approximately ten million deaths globally in 2022, making it the top cause of death worldwide. Additionally, when it comes to new cancer diagnoses globally, the most prevalent types were 2.26 million instances of breast cancer, 2.21 million instances of lung cancer, 1.4 million instances of prostate cancer, 1.20 million instances of skin cancer, 1.93 million instances of colon & rectum cancer, and 1.09 million instances of stomach cancer. The American Cancer Society's report for 2022 revealed approximately 1.8 million new cancer diagnoses and 606,520 reported cancer-related deaths in the United States.
Electroporation Instrument Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.00% over the forecast period (2024-2032)
Eukaryotic Electroporation Systems are expected to have the most market share by 2023, according to product type segmentation.
In 2023, Therapeutic Delivery was the most common application segmentation.
In 2023, North America was the region with the highest revenue.
The Global Electroporation Instrument Market is segmented on the basis of Product Type, Application, End User, and Region.
The market is divided into two categories based on product type: Eukaryotic Electroporation System and Microbial Electroporation System. In 2023, the Eukaryotic Electroporation Systems segment will account for the greatest proportion of the global Electroporation Instruments market. Electroporation is a commonly used method for transfecting eukaryotic cells. This type of gene delivery is used to stably or transiently transfected cells in order to examine protein expression, to knock out or "silence" genes temporarily, or to stably integrate the gene into the cell's genome for long-term protein expression. Increased research and development activities on protein expression and related therapeutic techniques are driving the growth of the Eukaryotic Electroporation Systems market.
The market is divided into three categories based on application: Protein Production, Biomedical Research and Therapeutics. Therapeutic Delivery has the greatest market share in 2023 and is predicted to grow at the highest CAGR during the forecast period (2024-2032). Because of the advantages of electroporation for transdermal drug delivery, it is an appealing alternative to traditional drug delivery methods such as oral administration and injection. However, the subcutaneous layer presents a significant barrier to most water-soluble and hydrophobic medicines. It contributes the majority of the skin's electric resistance, which can be overcome by electroporation, as it temporarily permeabilizes the skin, allowing for drug delivery.
Electroporation Instrument Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. These regions are further divided according to the nations bringing business. In 2023, the North American region held the majority of the share. This region's dominance stems from a higher frequency of chronic diseases and the availability of the most advanced and robust healthcare infrastructure. This region's supremacy is partly attributed to significant R&D investments and funding by leading market players.
The Asia-Pacific market is predicted to develop at a considerable CAGR due to the region's growing population. The Asia-Pacific region is emerging as a key development area for the electroporation instrument market. Rapid economic expansion, notably in China and India, is fueling investment in healthcare infrastructure and research. As a result, the demand for electroporation tools at academic institutions and biotechnology companies is increasing. The region's broad healthcare ecosystem allows for both basic research and clinical uses of electroporation technologies.
The Electroporation Instruments market is highly competitive, with both major and small growing companies. Companies, healthcare insurance providers, and hospitals are all competing in the Electroporation Instruments market. Key players such as Sigma-Aldrich Co. LLC, Harvard Bioscience, Inc, Biotron Healthcare, and Thermo Fisher Scientific, among others, compete on the basis of aggressive prices, features, ease of use, technological advancements, and marketing methods. To increase their footprint, market participants use a variety of essential techniques, including collaborations, partnerships, acquisitions, and product launches.
In April 2022, Thermo Fisher Scientific Inc., an American producer of scientific apparatus, reagents, consumables, and software services, introduced the Gibco CTS Xenon Electroporation System.
GLOBAL ELECTROPORATION INSTRUMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Sigma-Aldrich Co. LLC
Harvard Bioscience, Inc
Biotron Healthcare
Thermo Fisher Scientific
Eppendorf AG.
Bio-Rad Laboratories, Inc
Lonza Group
Others